Zobrazeno 1 - 10
of 80
pro vyhledávání: '"C E Angermann"'
Digital Technologies to Support Better Outcome and Experience of Care in Patients with Heart Failure
Publikováno v:
Current Heart Failure Reports. 19:75-108
Purpose of ReviewIn this article, we review a range of digital technologies for possible application in heart failure patients, with a focus on lessons learned. We also discuss a future model of heart failure management, as digital technologies conti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::416dd03c1e7237e43137913842ec33ff
https://doi.org/10.1007/s11897-022-00548-z
https://doi.org/10.1007/s11897-022-00548-z
Autor:
F Kerwagen, F Sahiti, S Sehner, J Albert, V Cejka, N Moser, C Morbach, G Gueder, S Frantz, G Ertl, C E Angermann, S Stoerk
Publikováno v:
European Heart Journal. 43
Background The association of clinically meaningful changes in the Kansas City Cardiomyopathy Questionnaire Overall Summary score (KCCQ-os) with prognosis in patients with heart failure (HF) is well established. However, most studies have considered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e62d5e50edafe6dfbbecd7605f897fd0
https://doi.org/10.1093/eurheartj/ehac544.892
https://doi.org/10.1093/eurheartj/ehac544.892
Autor:
F Kerwagen, F Sahiti, S Sehner, J Albert, V Cejka, N Moser, C Morbach, G Gueder, S Frantz, G Ertl, C E Angermann, S Stoerk
Publikováno v:
European Heart Journal. 43
Background Mid-regional proadrenomedullin (MR-proADM) is a blood biomarker indicating critical illness. Its short-term prognostic relevance has been investigated in several conditions including heart failure (HF). Yet, the long-term prognostic utilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2c2a65cdabf285057ac88dfac2d0f9c
https://doi.org/10.1093/eurheartj/ehac544.920
https://doi.org/10.1093/eurheartj/ehac544.920
Publikováno v:
Current heart failure reports. 19(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8d482a58580868b20b2a9020dd499f5
https://pubmed.ncbi.nlm.nih.gov/35441250
https://pubmed.ncbi.nlm.nih.gov/35441250
Publikováno v:
Mediators of Inflammation, Vol 2013 (2013)
Introduction. Experimental data indicates an important role of the innate immune system in cardiac remodeling and heart failure (HF). Complement is a central effector pathway of the innate immune system. Animals lacking parts of the complement system
Externí odkaz:
https://doaj.org/article/b06b9befc58448149bacf58709b296b1
Autor:
C. E. Angermann, S. Rosenkranz
Publikováno v:
Der Internist. 59:1041-1053
Herzinsuffizienz ist mit hoher Sterblichkeit, haufigen Krankenhausaufnahmen, schlechter Lebensqualitat und steigenden Kosten assoziiert. Trotz Fortschritten bei medikamentosen und Device-basieren Therapien bleiben Mortalitat und Morbiditat nach Ersth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28fbdd0cb959485fc3875fa1ccc32de4
https://doi.org/10.1007/s00108-018-0495-1
https://doi.org/10.1007/s00108-018-0495-1
Autor:
C. E. Angermann, J. Wallenborn
Publikováno v:
CME. 14:49-60
Herzinsuffizienz und Depression sind Volkskrankheiten von besonderer klinischer und okonomischer Relevanz. Verglichen mit der Normalbevolkerung findet sich bei Patienten mit Herzinsuffizienz eine komorbide Depression bis zu funfmal haufiger. Dies hat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2205a78b223d710e8df48364bfb947d
https://doi.org/10.1007/s11298-017-5973-6
https://doi.org/10.1007/s11298-017-5973-6
Autor:
H. Gunold, C. E. Angermann
Publikováno v:
Aktuelle Kardiologie. 4:379-386
Herzinsuffizienz beeintrachtigt die Lebenserwartung und die Lebensqualitat. Neben belastenden korperlichen Symptomen sind dafur kognitive Dysfunktion, Depression und Angst verantwortlich. Diese psychischen Komorbiditaten sind bei Herzinsuffizienten v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65058092c2ccf69b8186bab08b439ac9
https://doi.org/10.1055/s-0041-108096
https://doi.org/10.1055/s-0041-108096
Autor:
C E, Angermann, S, Rosenkranz
Publikováno v:
Der Internist. 59(10)
Heart failure (HF) is an emerging epidemic associated with significant morbidity and mortality, impaired quality of life and high healthcare costs. Despite major advances in pharmacological and device-based therapies, mortality and morbidity have rem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4290399c8e5afeb3eca3b9039fae24d5
https://pubmed.ncbi.nlm.nih.gov/30238134
https://pubmed.ncbi.nlm.nih.gov/30238134
Publikováno v:
Herz. 42(1)
Heart failure remains a frequent cause of death and is the leading reason for hospitalization in Germany although therapeutic options have significantly increased over the past years particularly in heart failure with reduced ejection fraction. Clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60da1307af58d6abe7b4ecb6b620c713
https://pubmed.ncbi.nlm.nih.gov/28105480
https://pubmed.ncbi.nlm.nih.gov/28105480